MarginsXMarginsX
Home › Markets › PRPH

ProPhase Labs, Inc. (PRPH)

PRPH is quoted over the counter, not listed on an exchange. ProPhase Labs, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 16, 2026
$0.0050
-50.0% on the day
1-year return
-99.8%
Market cap
$78K
Nano cap. From the Nov 16, 2026 close × 15.6M shares (10-Q cover page, Aug 17, 2026)
P/E and P/S
Net loss over the period · 0.0×
On trailing twelve months to June 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-16.

Profile

FieldValue
TickerPRPH, quoted over the counter
SEC CIK0000868278
OTC Markets tierOTCID (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressNew York, NY
Incorporated inDE

Warning signs

Cash runway
0.0 months
$20K cash at June 30, 2026
Share count, 1 year
+275.4%
2025-08-11 to 2026-08-17 · +825.6% over 3 years
Going-concern doubt
Yes
10-Q filed August 19, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued."
10-Q 2026-08-19
Cash and burn$20K cash; operating cash flow -$1.4M a quarter.Report 2026-06-30
Shares outstanding15,592,556 (2026-08-17); 41,541,205 a year earlier; 16,845,029 three years earlier. 1y figure adjusted for splits (1-for-10 overall); 3y figure adjusted for splits (1-for-10 overall).Cover page 2026-08-17
Reverse splits, 3 years1; latest 1-for-10 on 2025-12-22Source 2025-12-22
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2025-12-29
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-01-02
Delisting25-NSE filed25-NSE 2026-01-23
AuditorFruci & Associates II, PLLC, Spokane, Washington, United StatesPCAOB Form AP 2026-06-14
Late filings, 12 months3 NT noticesNT 10-Q 2026-08-14
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$1.0M-$3.1M-$78K$20K$438K$3.8M10-Q 2026-08-19
Q1 2026
2026-03-31
$1.2M-$5.2M-$748K$31K$304K$4.1M10-Q/A 2026-07-09
Q4 2025
2025-12-31
$784K-$7.4M-$1.2M$90K$244K$4.3M10-K 2026-06-01
Q3 2025
2025-09-30
$883K-$6.8M-$3.5M$405K$517K$5.1M10-Q 2025-11-19
Q2 2025
2025-06-30
$1.2M-$4.5M-$247K$169KNo debt tags$5.6M10-Q 2026-08-19
Q1 2025
2025-03-31
$1.4M$4.0M-$3.4M$88K$2.5M$5.8M10-Q/A 2026-07-09
Q4 2024
2024-12-31
$1.5M-$34.4M-$3.5M$678K$3.2M$6.8M10-K 2026-06-01
Q3 2024
2024-09-30
$1.4M-$6.6M-$4.0M$501K$2.7M-$625K10-Q 2025-11-19

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52025-12-29
Latest annual report10-K2026-06-01
Latest quarterly / interim10-Q2026-08-19
Latest current report8-K2026-08-06
Latest proxyDEF 14A2025-10-31

Source: SEC EDGAR submissions feed, 924 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier